What Happened
The Justice Department announced that Ruthia He, founder and former CEO of Done Global Inc., was sentenced to six years in prison and fined $1 million for a scheme involving unlawful distribution of more than 37 million Adderall pills, over $12 million in insurer fraud, and obstruction of a federal investigation.
David Brody, Done's former clinical president, was separately sentenced to two years in prison and fined $1 million. DOJ says the company used its technology platform, compensation structure, and clinical protocols to corrupt medical decision-making at national scale.
According to prosecutors, Done spent more than $40 million on social media ads, pushed easy access to stimulants through a monthly subscription model, and used auto-refill systems to keep prescriptions moving. DOJ says some clinicians were paid up to $60,000 per month while signing Adderall prescriptions every 30 seconds.
Why This Matters
Telehealth can be useful. It can also become a beautifully designed vending machine for bad incentives if the company treats patient care like user acquisition. DOJ's version of this case is exactly that nightmare: growth metrics, subscription revenue, automated refill friction removal, and controlled substances all jammed into one investor-friendly dashboard.
The details are ugly. Prosecutors say some patients continued to receive Adderall through psychiatric crises, family warnings, and even after death. Brody allegedly wrote prescriptions for 394,324 Schedule II stimulant pills for 6,559 Done members he never evaluated or whose records he never reviewed.
The Dumb Part
The dumb part is not that tech people discovered health care. The dumb part is that they apparently discovered health care and immediately asked, "What if the controlled-substance refill process worked more like a streaming subscription?"
DOJ says one executive joked about buying an expensive luxury car for the "first person to get arrested." That is not compliance culture. That is a future exhibit label.
The Bottom Line
The pitch was modern convenience. The result, according to DOJ, was a national pill pipeline with auto-refills, weak oversight, insurer fraud, and patients treated like monthly recurring revenue. Silicon Valley did not need to disrupt medicine this hard.
Sources
DOJ News: Office of Public Affairs releases